Honorable Four Price, Chair, House Committee on Public Health
FROM:
Ursula Parks, Director, Legislative Budget Board
IN RE:
HB810 by Parker (Relating to the provision of certain investigational stem cell treatments to patients with certain severe chronic diseases or terminal illnesses.), As Introduced
No significant fiscal implication to the State is anticipated.
The bill would amend Health and Safety Code Chapter 1003 to require the Health and Human Services Commission to adopt rules designating medical conditions that are recognized to be a severe chronic disease or a terminal illness. The bill would allow patients with such medical conditions to access and use investigational stem cell treatment if certain requirements have been met. The bill would take effect immediately upon receiving a two-thirds majority vote in each house. Otherwise, the bill would take effect September 1, 2017.
According to the Health and Human Services Commission and the Texas Medical Board, duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies:
503 Texas Medical Board, 529 Health and Human Services Commission